Kapitel 1067: Chapter 528: What Exactly is the Problem?_1

The international medical community has long researched the technology of using specific antibodies to label cancer cells.

In fact, in most cases, cancer immunotherapy refers to the use of specific antibodies to label cancer cells. That is, a specific antibody is artificially manufactured for a patient's cancer cells and, once injected into the human bloodstream, can activate the immune system to eradicate cancer cells.

This method belongs to passive immunotherapy for tumors and is also known as monoclonal antibody cancer treatment.

Monoclonal antibody cancer treatment requires genetic extraction and testing for each patient, followed by the production of targeted antibodies, making it extremely costly.

Thus, internationally, cancer immunotherapy treatments can cost millions of RMB per injection, not affordable for the general population.